Publications
2023
An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+with aortic stenosis in the UK
Malcolm, R., Buckley, C., Shore, J., Stainthorpe, A., Marti, B., White, A., . . . Wendler, O. (2023). An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+with aortic stenosis in the UK. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. doi:10.1080/14737167.2023.2249611
Health economic analysis of the integrated cognitive assessment tool to aid dementia diagnosis in the United Kingdom.
Shore, J., Kalafatis, C., Stainthorpe, A., Modarres, M. H., & Khaligh-Razavi, S. -M. (2023). Health economic analysis of the integrated cognitive assessment tool to aid dementia diagnosis in the United Kingdom.. Frontiers in public health, 11, 1240901. doi:10.3389/fpubh.2023.1240901
Economic evaluation of 27,540 patients with mood and anxiety disorders and the importance of waiting time and clinical effectiveness in mental healthcare
Catarino, A., Harper, S., Malcolm, R., Stainthorpe, A., Warren, G., Margoum, M., . . . Welchman, A. E. (n.d.). Economic evaluation of 27,540 patients with mood and anxiety disorders and the importance of waiting time and clinical effectiveness in mental healthcare. Nature Mental Health, 1(9), 667-678. doi:10.1038/s44220-023-00106-z
2022
Economic evaluation of a vision-based patient monitoring and management system in an acute adult and an older adult mental health hospital in England
Malcolm, R., Shore, J., Stainthorpe, A., Ndebele, F., & Wright, K. (2022). Economic evaluation of a vision-based patient monitoring and management system in an acute adult and an older adult mental health hospital in England. JOURNAL OF MEDICAL ECONOMICS, 25(1), 1207-1217. doi:10.1080/13696998.2022.2147753
Economic evaluation of a vision-based patient monitoring and management system in addition to standard care for adults admitted to psychiatric intensive care units in England
Malcolm, R., Shore, J., Stainthorpe, A., Ndebele, F., & Wright, K. (2022). Economic evaluation of a vision-based patient monitoring and management system in addition to standard care for adults admitted to psychiatric intensive care units in England. JOURNAL OF MEDICAL ECONOMICS, 25(1), 1101-1109. doi:10.1080/13696998.2022.2120719
2021
Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making
Gordon, J., Stainthorpe, A., Jones, B., Jacob, I., Hertel, N., Diaz, J., . . . Borrill, J. (2021). Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making. PHARMACOECONOMICS-OPEN, 5(4), 701-713. doi:10.1007/s41669-021-00279-2
2020
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Stainthorpe, A., Fleeman, N., Houten, R., Chaplin, M., Boland, A., Beale, S., . . . Syndikus, I. (2020). Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 4(4), 563-574. doi:10.1007/s41669-020-00203-0
Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
Duarte, R., Stainthorpe, A., Greenhalgh, J., Richardson, M., Nevitt, S., Mahon, J., . . . Takwoingi, Y. (2020). Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24(3), 1-+. doi:10.3310/hta24030
2019
Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation
Duarte, R., Stainthorpe, A., Mahon, J., Greenhalgh, J., Richardson, M., Nevitt, S., . . . Takwoingi, Y. (2019). Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation. PLOS ONE, 14(12). doi:10.1371/journal.pone.0226671
2018
Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12)
Fleeman, N., Stainthorpe, A., Houten, R., Chaplin, M., Boland, A., Beale, S., . . . Isabel, S. (2018). Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12): Brentuximab vedotin for treating relapsed or refractory CD30- positive cutaneous T-cell lymphoma (17/56/12). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta577/documents/committee-papers
Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Stainthorpe, A., Greenhalgh, J., Bagust, A., Richardson, M., Boland, A., Beale, S., . . . Palmer, D. (2018). Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(10), 1153-1163. doi:10.1007/s40273-018-0646-1
Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Fleeman, N., Abdulla, A., Bagust, A., Beale, S., Richardson, M., Stainthorpe, A., . . . Palmer, D. (2018). Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 36(3), 289-299. doi:10.1007/s40273-017-0592-3
2017
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Fleeman, N., Bagust, A., Boland, A., Beale, S., Richardson, M., Krishan, A., . . . Payne, M. (2017). Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 35(10), 1035-1046. doi:10.1007/s40273-017-0504-6
Nab-paclitaxel with gemcitabine for 1st line metastatic pancreatic adenocarcinoma
Greenhalgh, J. (n.d.). Nab-paclitaxel with gemcitabine for 1st line metastatic pancreatic adenocarcinoma (ID1058). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta476/documents/committee-papers
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer
Greenhalgh, J., Bagust, A., Stainthorpe, A., Chaplin, M., Boland, A., De Sousa Rego Vieira Duarte, R., . . . Palmer, D. (2017). Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer: Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer (14/90/01). NICE website. Retrieved from https://www.nice.org.uk/guidance/ta476/documents/committee-papers
2016
Cost Effectiveness Modelling for Health Technology Assessment: A Practical Course
Abdulla, A., & Stainthorpe, A. (2016). Cost Effectiveness Modelling for Health Technology Assessment: A Practical Course. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 14(6), 733-734. doi:10.1007/s40258-016-0242-5
Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer
Greenhalgh, J. (n.d.). Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer (ID915). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta495/documents/committee-papers-2
Eribulin for locally advanced or metastatic breast cancer
Greenhalgh, J. (n.d.). Eribulin for locally advanced or metastatic breast cancer (ID964). NICE Website. Retrieved from https://www.nice.org.uk/guidance/gid-ta10030/documents/committee-papers
Nanoliposomal irinotecan for treating pancreatic cancer after prior treatment with gemcitabine
Greenhalgh, J. (n.d.). Nanoliposomal irinotecan for treating pancreatic cancer after prior treatment with gemcitabine (ID778). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta440/documents/committee-papers-2
Nivolumab for treating metastatic, non-squamous, non-small-cell lung cancer after chemotherapy
Greenhalgh, J. (n.d.). Nivolumab for treating metastatic, non-squamous, non-small-cell lung cancer after chemotherapy (ID900). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta484/documents/committee-papers
Talimogene laherparepvec for treating metastatic melanoma
Fleeman, N., Bagust, A., Boland, A., Beale, S., Chaplin, M., Krishan, A., . . . Payne, M. (2016). Talimogene laherparepvec for treating metastatic melanoma: Talimogene laherparepvec for treating metastatic melanoma (14/206/04). NICE Website. Retrieved from https://www.nice.org.uk/guidance/gid-tag509/documents/committee-papers-2
2015
Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab
Fleeman, N., Bagust, A., Chaplin, M., Krishan, A., Boland, A., Beale, S., . . . Payne, M. (2015). Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab: Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab (14/177/07). NICE Website. Retrieved from https://www.nice.org.uk/
Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab
Greenhalgh, J., Mahon, J., Chaplin, M., Krishan, A., Aslam, R., Beale, S., . . . Payne, M. (2015). Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab: Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab (14/177/06). NICE website. Retrieved from https://www.nice.org.uk/guidance/TA366/documents/committee-papers